Roof Eidam & Maycock Novavax Inc Transaction History
Roof Eidam & Maycock
- $382 Million
- Q4 2024
A detailed history of Roof Eidam & Maycock transactions in Novavax Inc stock. As of the latest transaction made, Roof Eidam & Maycock holds 10,000 shares of NVAX stock, worth $78,700. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$78,700
Previous $126,000
36.51%
% of portfolio
0.02%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$124 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$93.2 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$87.7 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$60.6 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$45.6 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $616M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...